Prenatal exclusion of recessively inherited disorders: Should maternal plasma analysis precede invasive techniques?

Clinical Chemistry

Volumn 48, Issue 5, 2002, Pages 689-690

  Bianchi, Diana W ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DNA SEQUENCE; EDITORIAL; GENETIC DISORDER; HUMAN; MATERNAL BLOOD; PRENATAL DIAGNOSIS; RECESSIVE INHERITANCE;

EID: 0036225458     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.5.689     Document Type: Editorial

References (15)

1. Presence of fetal DNA in maternal plasma and serum
2. Fetal DNA in maternal plasma: Emerging clinical applications
3. Increased fetal DNA concentrations in the plasma of women carrying fetuses with trisomy 21
4. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum
5. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses
6. Increased cell-free fetal DNA in plasma of two women with invasive placenta
7. Maternal plasma fetal DNA concentrations as a marker for preterm labour
8. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma
9. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma
10. Prenatal diagnosis of a single-gene disorder from maternal plasma
11. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: A feasibility study
12. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia
13. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies
14. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia
15. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum